Quiver Bioscience Competitors and Similar CompaniesClear all
Quiver Bioscience's competitors and similar companies include Relay Therapeutics, SINOVAC, Zhaoke Ophthalmology and Walvax Biotechnology.
 Quiver Bioscience Quiver Bioscience (also known as Q-State Biosciences) is a precision medicine company that develops drugs for neurological diseases. |  Relay Therapeutics Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities. |  SINOVAC SINOVAC is a biopharmaceutical company that has expertise in the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases. |  Zhaoke Ophthalmology Zhaoke Ophthalmology (兆科眼科) is a company that produces and commercializes ophthalmic products. |  Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | |
Founding Date | Founding Date 2013 | Founding Date 2016 | Founding Date 2001 | Founding Date 2017 | Founding Date 2001 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Cambridge, US HQ | Locations CN HQ | Locations George Town, KY HQ | Locations Kunming, CN HQ |
Employees | Employees 41 | Employees 2724% decrease | Employees 2111% decrease | Employees 294 | Employees 2,388 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 958.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $15.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥32m (FY, 2025) | Revenue (est.) ¥2.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥15.9m (FY, 2025) | Cost of goods ¥615.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit ¥16.8m (FY, 2025) | Gross profit ¥1.8b (FY, 2025) |
Net income | Net income N/A | Net income ($276.5m) (FY, 2025) | Net income N/A | Net income (¥209m) (FY, 2025) | Net income ¥125.2m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 520m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 72.8m |
For sources of this data, please see the company profile
View Company Profiles
Relay Therapeutics
HQ
Cambridge, US
Employees
272↓ 4% decrease
Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.
View companySINOVAC
HQ
CN
Employees
211↓ 1% decrease
SINOVAC is a biopharmaceutical company that has expertise in the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases.
View companyZhaoke Ophthalmology
HQ
George Town, KY
Employees
294
Zhaoke Ophthalmology (兆科眼科) is a company that produces and commercializes ophthalmic products.
View companyWalvax Biotechnology
HQ
Kunming, CN
Employees
2,388
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View company